News

We are pleased to announce that on January 7, 2021, Advantage Partners Asia Fund and affiliated entities (collectively “AP Funds”) invested in Pharmaforte (Malaysia) Sdn. Bhd. and Pharmaforte Singapore Pte Ltd (collectively, “Pharmaforte Group” or the “Group”), a sales and marketing agency and distributor of healthcare products including pharmaceuticals, medical supplies and equipment, and consumer/personal care products in Malaysia and Singapore.

Pharmaforte Group provides integrated value chain services from drug registration to distribution. The Group represents blue-chip multinational healthcare principals with specialization in major medical therapeutic areas including cardiology, psychiatry, and radiology, amongst others. The Group serves a diversified customer base including clinics, retail pharmacies, government bodies and private hospitals in Malaysia and Singapore.

AP Funds were attracted to Pharmaforte Group due to the Group’s extensive sales network coverage and excellent operational track record that enables the Group to be a trusted partner to multinational healthcare principals as well as the robust underlying demand for medical services and products in Malaysia and Singapore. Post investment, AP Funds will collaborate closely with Pharmaforte Group’s management to accelerate growth, integrate operations and extract synergies, and build on the existing platform to create a leading regional healthcare distribution group.

Details of Pharmaforte Group
Company Name:     Pharmaforte (Malaysia) Sdn. Bhd.
Founder:                  Yeo Ann Chin
Location:                 Kuala Lumpur, Malaysia
Business Description:             Sales and marketing agency of healthcare products

Company Name:     Pharmaforte Singapore Pte Ltd
Founder:                  Kwan Yew Huat
Location:                 Singapore
Business Description:             Sales and marketing agency of healthcare products

(日本語) PDF DOWNLOAD